MYD88 and B-cell chronic lymphocytic leukemia: A study presented by the Martínez-Trillos team in 2014 [58] evaluated the occurrence and characteristics of mutations in the TLR2, TLR5, and TLR6 receptor genes and myeloid differentiation of the primary response 88 (MYD88) in patients with CLL.